224 related articles for article (PubMed ID: 25962161)
1. Cream formulation impact on topical administration of engineered colloidal nanoparticles.
Santini B; Zanoni I; Marzi R; Cigni C; Bedoni M; Gramatica F; Palugan L; Corsi F; Granucci F; Colombo M
PLoS One; 2015; 10(5):e0126366. PubMed ID: 25962161
[TBL] [Abstract][Full Text] [Related]
2. Topical drug delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in vivo skin distribution studies.
Batheja P; Sheihet L; Kohn J; Singer AJ; Michniak-Kohn B
J Control Release; 2011 Jan; 149(2):159-67. PubMed ID: 20950659
[TBL] [Abstract][Full Text] [Related]
3. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route.
Lauterbach A; Müller-Goymann CC
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):152-63. PubMed ID: 26144664
[TBL] [Abstract][Full Text] [Related]
4. Combined multiphoton imaging-pixel analysis for semiquantitation of skin penetration of gold nanoparticles.
Labouta HI; Kraus T; El-Khordagui LK; Schneider M
Int J Pharm; 2011 Jul; 413(1-2):279-82. PubMed ID: 21515347
[TBL] [Abstract][Full Text] [Related]
5. Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluations.
Erdal MS; Özhan G; Mat MC; Özsoy Y; Güngör S
Int J Nanomedicine; 2016; 11():1027-37. PubMed ID: 27042058
[TBL] [Abstract][Full Text] [Related]
6. Lipid nanoparticles for dermal drug delivery.
Kakadia PG; Conway BR
Curr Pharm Des; 2015; 21(20):2823-9. PubMed ID: 25925115
[TBL] [Abstract][Full Text] [Related]
7. Impact of semi-solid formulations on skin penetration of iron oxide nanoparticles.
Musazzi UM; Santini B; Selmin F; Marini V; Corsi F; Allevi R; Ferretti AM; Prosperi D; Cilurzo F; Colombo M; Minghetti P
J Nanobiotechnology; 2017 Feb; 15(1):14. PubMed ID: 28212635
[TBL] [Abstract][Full Text] [Related]
8. Dermal peptide delivery using enhancer moleculs and colloidal carrier systems. Part II: Tetrapeptide PKEK.
Neubert RHH; Sommer E; Schölzel M; Tuchscherer B; Mrestani Y; Wohlrab J
Eur J Pharm Biopharm; 2018 Mar; 124():28-33. PubMed ID: 29247690
[TBL] [Abstract][Full Text] [Related]
9. Dermal delivery of desmopressin acetate using colloidal carrier systems.
Getie M; Wohlrab J; Neubert RH
J Pharm Pharmacol; 2005 Apr; 57(4):423-7. PubMed ID: 15831201
[TBL] [Abstract][Full Text] [Related]
10. Topical delivery of lipophilic drugs from o/w Pickering emulsions.
Frelichowska J; Bolzinger MA; Pelletier J; Valour JP; Chevalier Y
Int J Pharm; 2009 Apr; 371(1-2):56-63. PubMed ID: 19135516
[TBL] [Abstract][Full Text] [Related]
11. Delivery and targeting of nanoparticles into hair follicles.
Fang CL; Aljuffali IA; Li YC; Fang JY
Ther Deliv; 2014; 5(9):991-1006. PubMed ID: 25375342
[TBL] [Abstract][Full Text] [Related]
12. Do nanoparticles have a future in dermal drug delivery?
Patzelt A; Mak WC; Jung S; Knorr F; Meinke MC; Richter H; Rühl E; Cheung KY; Tran NBNN; Lademann J
J Control Release; 2017 Jan; 246():174-182. PubMed ID: 27641832
[TBL] [Abstract][Full Text] [Related]
13. Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis.
Lapteva M; Mondon K; Möller M; Gurny R; Kalia YN
Mol Pharm; 2014 Sep; 11(9):2989-3001. PubMed ID: 25057896
[TBL] [Abstract][Full Text] [Related]
14. Enhanced skin penetration of lidocaine through encapsulation into nanoethosomes and nanostructured lipid carriers: a comparative study.
Babaei S; Ghanbarzadeh S; Adib ZM; Kouhsoltani M; Davaran S; Hamishehkar H
Pharmazie; 2016 May; 71(5):247-51. PubMed ID: 27348967
[TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, Part II--in vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis.
Pople PV; Singh KK
Eur J Pharm Biopharm; 2013 May; 84(1):72-83. PubMed ID: 23246619
[TBL] [Abstract][Full Text] [Related]
16. Delving Deeper into Dermal and Transdermal Drug Delivery: Factors and Mechanisms Associated with Nanocarrier-mediated Strategies.
Manikkath J; Sumathy TK; Manikkath A; Mutalik S
Curr Pharm Des; 2018; 24(27):3210-3222. PubMed ID: 30246632
[TBL] [Abstract][Full Text] [Related]
17. Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles.
Andrade LM; de Fátima Reis C; Maione-Silva L; Anjos JL; Alonso A; Serpa RC; Marreto RN; Lima EM; Taveira SF
Eur J Pharm Biopharm; 2014 Sep; 88(1):40-7. PubMed ID: 24816130
[TBL] [Abstract][Full Text] [Related]
18. Glabridin nanosuspension for enhanced skin penetration: formulation optimization, in vitro and in vivo evaluation.
Wang WP; Hul J; Sui H; Zhao YS; Feng J; Liu C
Pharmazie; 2016 May; 71(5):252-7. PubMed ID: 27348968
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles made from novel starch derivatives for transdermal drug delivery.
Santander-Ortega MJ; Stauner T; Loretz B; Ortega-Vinuesa JL; Bastos-González D; Wenz G; Schaefer UF; Lehr CM
J Control Release; 2010 Jan; 141(1):85-92. PubMed ID: 19699771
[TBL] [Abstract][Full Text] [Related]
20. Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review.
Herman A; Herman AP
J Pharm Pharmacol; 2015 Apr; 67(4):473-85. PubMed ID: 25557808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
